pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·Sep 9·1 min read
save

Career setbacks offer data points, not definitive verdicts, says executive coach

Sep 9, 2026·read at BioSpace ↗Neutral

Angela Justice, an executive coach, describes how a sudden layoff can feel like a verdict but is really just a data point.

She warns that people often turn the specific lesson from a setback into a broad rule, such as believing loyalty is foolish after a layoff, which can limit future opportunities.

Justice advises professionals to reflect on the actual event without overgeneralizing, using the experience to inform choices while avoiding rigid rules that may hinder career growth.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “A career setback is a data point, not a verdict”

read at BioSpace ↗
1,131 words · retrieved Sep 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 13h agoBMS reveals death from septic pneumonia of multiple sclerosis patient in CAR T trialBioSpace
  • 14h agoAlnylam plans pivotal trial as Huntington’s drug notches ‘best-in-class knockdown’BioSpace
  • 14h agoESMO 2026: Tango trips on sinking response rates in pancreatic cancer but will move to Phase 3BioSpace
  • 15h agoTango plans 14% workforce cut, mainly of research staffBioSpace
  • 15h agoRoche flags ‘final opportunity’ for Germany to reestablish as a reliable investment locationBioSpace